Srs Capital Advisors, Inc. Dr Reddys Laboratories LTD Transaction History
Srs Capital Advisors, Inc.
- $8.6 Billion
- Q3 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 1,473 shares of RDY stock, worth $20,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,473
Previous 915
60.98%
Holding current value
$20,533
Previous $13,000
53.85%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RDY
# of Institutions
250Shares Held
94.4MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$182 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A610.2MShares$142 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.78MShares$122 Million0.17% of portfolio
-
Aikya Investment Management LTD London, X06.72MShares$93.6 Million26.28% of portfolio
-
Morgan Stanley New York, NY6.32MShares$88.1 Million0.01% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.31B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...